|
Action of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma
|
02 October 2013 |
|
Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue
|
30 September 2013 |
|
Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling
|
30 September 2013 |
|
Vitamin C decreases intracellular calcium level in human lymphoid cells
|
29 September 2013 |
|
Somatostatin induces migration of acute myeloid leukemia cells via activation of somatostatin receptor subtype 2
|
29 September 2013 |
|
Analyses of factors influencing the acute effect of octreotide in growth hormone-secreting adenomas
|
27 September 2013 |
|
Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan
|
26 September 2013 |
|
Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas
|
26 September 2013 |
|
Expression of prolactin and prolactin receptors by non-Hodgkin's lymphoma cells
|
24 September 2013 |
|
The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation
|
24 September 2013 |